Диссертация (1154834), страница 28
Текст из файла (страница 28)
Tack, J. Efficacy of Mirtazapine in patients with functional dyspepsiaand weight loss /Jan Tack, Huynh Giao Ly, Florencia Carbone // ClinicalGastrenterology and Hepatology. – 2016. – Vol. 14 (3). – P. 385-392.296. Thung, I. Review article: the global emergence of Helicobacter pyloriantibiotic resistance /I.Thung, H.Aramin, V. Vavinskaya [ et al. ] // AlimentPharmacol. Ther. –2016. – Vol.43.
– P.514-33.297. Tong, J. L. Meta-analysis: the effect of supplementation withprobiotics on eradication rates and adverse events during Helicobacter pylorieradication therapy / J.L. Tong, Z.H. Ran, J. Shen [ et al. ] // Aliment Pharmacol.Ther. –2007. – Vol. 25. – P. 155-168.298. Van den Brink, G.R. Expression and Activation of NF-B in theAntrum of the Human Stomach / G. R. Van den Brink, F.J. ten Kate, C. Y.Ponsioen [ et al. ] // J Immunology. – 2000. – Vol.
164. – P.3353-3359.299.Waluga, M. From the stomach to other organs: Helicobacter pyloriand the liver/ M. Waluga, M.Kukla, M. Їorniak [ et.al. ] // World J. Hepatol. –2015. – Vol. 7 (18). – P. 2136-2146.300. Wiklund, I. Quality of Life in Different Gastrointestinal Conditions /I.
Wiklund, H. Glise // Eur. J. Surg. – 1998. – Vol. 582. – P. 56-61.301. Xia, H.H. Antral-type mucosa in the gastric incisura, body, and fundus(antralization): a link between Helicobacter pylori infection and intestinalmetaplasia? / H.H. Xia // Am. J. Gastroenterol. – 2012. – Vol. 95 (1). – Р. 114-121.302. Yu, A.Q. The Potential Role of Probiotics in Cancer Prevention andTreatment / A.Q. Yu, L.Li // Nutr Cancer. –2016. –Vol. 68 (4).– P. 535-544.303.
Zhang, M. Probiotics in Helicobacter pylori eradication therapy: Asystematic review and meta-analysis / M. Zhang, W. Qian // World J.Gastroenterol. – 2015. – Vol. 21 (14). – P. 4345-4357..